Literature DB >> 24368696

Cholera outbreaks in the classical biotype era.

A K Siddique1, Richard Cash.   

Abstract

In the Indian subcontinent description of a disease resembling cholera has been mentioned in Sushruta Samita, estimated to have been written between ~400 and 500 BC. It is however not clear whether the disease known today as cholera caused by Vibrio cholerae Vibrio cholerae O1 is the evolutionary progression of the ancient disease. The modern history of cholera began in 1817 when an explosive epidemic broke out in the Ganges River Delta region of Bengal. This was the first of the seven recorded cholera pandemics cholera pandemics that affected nearly the entire world and caused hundreds of thousands of deaths. The bacterium responsible for this human disease was first recognised during the fifth pandemic and was named V. cholerae which was grouped as O1, and was further differentiated into Classical and El Tor biotypes. It is now known that the fifth and the sixth pandemics were caused by the V. cholerae O1 of the Classical biotype Classical biotype and the seventh by the El Tor biotype El Tor biotype . The El Tor biotype of V. cholerae, which originated in Indonesia Indonesia and shortly thereafter began to spread in the early 1960s. Within the span of 50 years the El Tor biotype had invaded nearly the entire world, completely displacing the Classical biotype from all the countries except Bangladesh. What prompted the earlier pandemics to begin is not clearly understood, nor do we know how and why they ended. The success of the seventh pandemic clone over the pre-existing sixth pandemic strain remains largely an unsolved mystery. Why classical biotype eventually disappeared from the world remains to be explained. For nearly three decades (1963-1991) during the Seventh cholera pandemic seventh pandemic, cholera in Bangladesh has recorded a unique history of co-existence of Classical and El Tor biotypes of V. cholerae O1 as epidemic and endemic strain. This long co-existence has provided us with great opportunity to improve our understanding of the disease itself and answer some important questions.

Entities:  

Mesh:

Year:  2014        PMID: 24368696     DOI: 10.1007/82_2013_361

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  11 in total

1.  Utilization of Small RNA Genes to Distinguish Vibrio cholerae Biotypes via Multiplex Polymerase Chain Reaction.

Authors:  Siti Aminah Ahmed; Carsten A Raabe; Hong Leong Cheah; Chee Hock Hoe; Timofey S Rozhdestvensky; Thean Hock Tang
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  Evaluation of Whole-Genome Sequencing for Identification and Typing of Vibrio cholerae.

Authors:  David R Greig; Ulf Schaefer; Sophie Octavia; Ebony Hunter; Marie A Chattaway; Timothy J Dallman; Claire Jenkins
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

3.  Diverse Aquatic Animal Matrices Play a Key Role in Survival and Potential Virulence of Non-O1/O139 Vibrio cholerae Isolates.

Authors:  Lili Yan; Yinzhe Jin; Beiyu Zhang; Yingwei Xu; Xu Peng; Si Qin; Lanming Chen
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

4.  Warming trend: how climate shapes Vibrio ecology.

Authors:  Sharon Levy
Journal:  Environ Health Perspect       Date:  2015-04       Impact factor: 9.031

5.  Socioeconomic and programmatic determinants of renewal of membership in a voluntary micro health insurance scheme: evidence from Chakaria, Bangladesh.

Authors:  Mohammad Iqbal; Asiful Haidar Chowdhury; Shehrin Shaila Mahmood; Mohammad Nahid Mia; S M A Hanifi; Abbas Bhuiya
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

Review 6.  Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming.

Authors:  Fazle Rabbi Chowdhury; Zannatun Nur; Nazia Hassan; Lorenz von Seidlein; Susanna Dunachie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-03-07       Impact factor: 3.944

7.  Vibrio cholerae O1 with Reduced Susceptibility to Ciprofloxacin and Azithromycin Isolated from a Rural Coastal Area of Bangladesh.

Authors:  Shah M Rashed; Nur A Hasan; Munirul Alam; Abdus Sadique; Marzia Sultana; Md Mozammel Hoq; R Bradley Sack; Rita R Colwell; Anwar Huq
Journal:  Front Microbiol       Date:  2017-02-21       Impact factor: 5.640

Review 8.  Pandemics Throughout History.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Front Microbiol       Date:  2021-01-15       Impact factor: 6.064

9.  The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.

Authors:  Ashraful Islam Khan; Ann Levin; Dennis L Chao; Denise DeRoeck; Dobromir T Dimitrov; Jahangir A M Khan; Muhammad Shariful Islam; Mohammad Ali; Md Taufiqul Islam; Abdur Razzaque Sarker; John D Clemens; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2018-10-09

Review 10.  Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review.

Authors:  Yahaya Mohammed; Aaron O Aboderin; Iruka N Okeke; Adebola T Olayinka
Journal:  Afr J Lab Med       Date:  2018-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.